+39.6%
MRNA vs AMDL
+95.0%
-55.4%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | AMDL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +9.2% | -11.4% | -3.2% |
| 7D | +5.5% | +4.5% | +0.9% | +4.9% |
| 30D | +158.7% | -4.4% | +163.1% | +157.7% |
| 3M | +182.1% | -30.5% | +212.6% | +183.3% |
| 6M | +151.8% | +300.9% | -149.1% | +86.3% |
| YTD | +393.6% | +219.9% | +173.6% | +269.6% |
| 1Y | +499.5% | +374.7% | +124.8% | +302.4% |
| All | +39.6% | +95.0% | -55.4% | -11.6% |
Cumulative growth
Daily Returns
Daily percentage return beside AMDL.
Daily Out/Under-Performance
Portfolio return minus AMDL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMDL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded AMDL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling